CaryRx

Operating

Cary Rx Inc

Healthcare

Visit website

Tech Enabled, On-Demand Pharmacy with Free Same-Day Delivery

Valuation cap ⓘ

$8.0M

As of Apr 2019 · from Reg CF Offering (2018) · a SAFE/note conversion ceiling, not a priced valuation

Total raised

$137,415

Across 1 round since 2018

Financials

FY2016–FY2017 · from SEC filings · hover any figure for its source

−$53K

2016

$59K

−$137K

2017

RevenueNet income — beside revenue when positive, below the line when a loss

Metric

FY2016 reviewed*

FY2017 reviewed*

Income statement

Revenue

$58,646

Cost of goods sold

$57,209

Gross margin

—

Net income

-$53,209

-$137,476

Taxes paid

$175

$475

Balance sheet

Cash

-$628

$15,950

Accounts receivable

Total assets

$66,884

$156,075

Short-term debt

$11,068

$119,224

Long-term debt

$45,676

$161,375

Total liabilities

$56,744

$280,599

Other

Headcount

—

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Valuation caps on SAFE / convertible note rounds

$8.0M

Valuation cap

Reg CF · SAFE · Nov 2018

Dashed amber bars are a SAFE or convertible note's valuation cap — the most it converts at, not what the company is worth.

Fundraising history

Reg CF · SAFE · Nov 2018Closedvia WeFunder

Raised $137.4K / $1.1MInvestors 158Valuation cap $8M

Team

2 people

Areo NazariFounder

CEO and Founder

Kevin Lance

Secretary

Names and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Delinquent

Filed 0 of 8 annual reports (FY2018–FY2025)

Missing: 2018, 2019, 2020, 2021, 2022, 2023, 2024, 2025

158 investors

holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

Form C/AFeb 22, 20190001670254-19-000081
EDGAR
Form CNov 13, 20180001670254-18-000536
EDGAR

Source: ManualCIK 0001757903

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.